Revascularization After Intravitreal Bevacizumab and Laser Therapy of Bilateral Retinal Vascular Occlusions in Incontinentia Pigmenti (Bloch-Sulzberger Syndrome)

Copyright 2019, SLACK Incorporated.

Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging retina. - 2013. - 50(2019), 2 vom: 01. Feb., Seite e33-e37
1. Verfasser: Cernichiaro-Espinosa, Linda A (VerfasserIn)
Weitere Verfasser: Patel, Nimesh A, Bauer, Mislen S, Negron, Catherin I, Fallas, Brenda, Pogrebniak, Alexander, Berrocal, Audina M
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Ophthalmic surgery, lasers & imaging retina
Schlagworte:Case Reports Journal Article Angiogenesis Inhibitors Bevacizumab 2S9ZZM9Q9V
LEADER 01000naa a22002652 4500
001 NLM293937028
003 DE-627
005 20231225080412.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||eng c
024 7 |a 10.3928/23258160-20190129-16  |2 doi 
028 5 2 |a pubmed24n0979.xml 
035 |a (DE-627)NLM293937028 
035 |a (NLM)30768227 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Cernichiaro-Espinosa, Linda A  |e verfasserin  |4 aut 
245 1 0 |a Revascularization After Intravitreal Bevacizumab and Laser Therapy of Bilateral Retinal Vascular Occlusions in Incontinentia Pigmenti (Bloch-Sulzberger Syndrome) 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 08.04.2019 
500 |a Date Revised 08.04.2019 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Copyright 2019, SLACK Incorporated. 
520 |a No consensus exists for the treatment of retinopathy in incontinentia pigmenti (IP). Vascular ischemia leads to tractional retinal detachments if untreated. Ultra-widefield fluorescein angiography (FA) is used to follow the vascular status of the retina. A 13-week-old female with IP presented with bilateral retinal vascular occlusions in both eyes. Ultra-widefield FA showed reperfusion after treatment with intravitreal bevacizumab (IVB) and angiography-guided laser to the avascular retina. Anti-vascular endothelial growth factor treatment reduces neovascularization and allows for growth of retinal vessels. IVB and FA-guided laser to the avascular retina is an option in IP. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e33-e37.] 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 7 |a Angiogenesis Inhibitors  |2 NLM 
650 7 |a Bevacizumab  |2 NLM 
650 7 |a 2S9ZZM9Q9V  |2 NLM 
700 1 |a Patel, Nimesh A  |e verfasserin  |4 aut 
700 1 |a Bauer, Mislen S  |e verfasserin  |4 aut 
700 1 |a Negron, Catherin I  |e verfasserin  |4 aut 
700 1 |a Fallas, Brenda  |e verfasserin  |4 aut 
700 1 |a Pogrebniak, Alexander  |e verfasserin  |4 aut 
700 1 |a Berrocal, Audina M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmic surgery, lasers & imaging retina  |d 2013  |g 50(2019), 2 vom: 01. Feb., Seite e33-e37  |w (DE-627)NLM224956647  |x 2325-8179  |7 nnns 
773 1 8 |g volume:50  |g year:2019  |g number:2  |g day:01  |g month:02  |g pages:e33-e37 
856 4 0 |u http://dx.doi.org/10.3928/23258160-20190129-16  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_40 
912 |a GBV_ILN_63 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_90 
912 |a GBV_ILN_91 
912 |a GBV_ILN_130 
912 |a GBV_ILN_135 
912 |a GBV_ILN_136 
912 |a GBV_ILN_151 
912 |a GBV_ILN_181 
912 |a GBV_ILN_203 
912 |a GBV_ILN_217 
912 |a GBV_ILN_235 
912 |a GBV_ILN_289 
912 |a GBV_ILN_294 
912 |a GBV_ILN_297 
912 |a GBV_ILN_350 
912 |a GBV_ILN_352 
912 |a GBV_ILN_674 
912 |a GBV_ILN_676 
912 |a GBV_ILN_688 
912 |a GBV_ILN_698 
912 |a GBV_ILN_721 
912 |a GBV_ILN_737 
912 |a GBV_ILN_791 
912 |a GBV_ILN_812 
951 |a AR 
952 |d 50  |j 2019  |e 2  |b 01  |c 02  |h e33-e37